Northern Trust Corp Astrazeneca PLC Transaction History
Northern Trust Corp
- $658 Billion
- Q1 2025
A detailed history of Northern Trust Corp transactions in Astrazeneca PLC stock. As of the latest transaction made, Northern Trust Corp holds 4,666,777 shares of AZN stock, worth $329 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
4,666,777
Previous 4,692,678
0.55%
Holding current value
$329 Million
Previous $307 Million
11.56%
% of portfolio
0.05%
Previous 0.04%
Shares
32 transactions
Others Institutions Holding AZN
# of Institutions
1,428Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.03 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.87 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.51 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.25 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.21 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $219B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...